| |
FT Digital Health Summit
|
| With Joshua Newman (Chief Medical Officer, Salesforce), Lloyd Minor (Dean, Stanford School of Medicine), Deneen Vojta (EVP R&D, UnitedHealth Group), Melissa Thompson (Memorial Sloan Kettering), Nelia Padilla (VP, Quintiles IMS), David Crow (Sr Business Correspondent, Financial Times). |
| The Westin New York at Times Square, 270 W 43rd St |
|
Oct 12 (Thu) , 2017 @ 08:00 AM
| |
$949 |
|
|
|
|
|
|
|
|
| |
/-73.98912811,40.75762558,13,0,0/550x200?access_token=pk.eyJ1IjoiZ2FyeXNndWlkZSIsImEiOiJjamtobmRiYmgwb3gwM3F1a2o2Mmd0YWw3In0.DinA62CR3-OKtf3axa5O7Q)
|
| |
| DETAILS |
|
Driving collaborative, patient-led health transformation
Digital technology continues to push the boundaries & offer solutions to ease the growing pressures of healthcare provision. Collaboration is key to addressing the challenges & realising a successful patient-centered future for healthcare. Novel partnerships & alliances are emerging & stakeholders are extending their reach beyond their traditional domains. Coordinated thinking & cooperation throughout the health value chain will help build an understanding of how to integrate new technologies, facilitate a smooth transition & ultimately reduce costs & improve patient outcomes.
The third instalment of the FT Digital Health Summit USA will take a fresh look at how patients, providers, payers, innovators, regulators & investors can work together to ensure that technology is consistent & effective in meeting the demands of patients & health services. Discussion will delve deep into the trends & opportunities & explore the funding, innovation & approaches needed to drive forward the digital age of health.
Assess how patients are continuing to take more control of their own value-based healthcare
Take home ideas that will allow your own business to specifically target the latest consumer & patient demands
Better identify cyber threats & reduce information security risks
Find out how innovators are closing the gap between product development & adoption
Hear the latest from pharma & biotech leaders who have strong influence on the digital uptake in medicine
|
|
|
|
|
|
|
|
